Core Insights - The introduction of export tariffs on soybeans and rapeseed has significantly impacted Ukraine's processing capacity, reaching its highest utilization rate in recent years [1][3] Group 1: Economic Impact - The Minister of Economy, Environment, and Agriculture, Oleksiy Sobolev, confirmed that the measures taken to stimulate processing have measurable effects, with oilseed processing currently at its highest level in years [3] - The government is promoting a policy that favors domestic processing of Ukrainian-grown agricultural products over direct exports, aiming to move away from a commodity-based economic model [3] Group 2: Production Forecast - Ukraine's soybean and rapeseed production is projected to reach 8 million tons by 2025, up from 6.4 million tons in 2021, indicating growth without additional support programs [3] - There is currently no need for extra incentives for these crops, and there are no plans to impose similar tariffs on other agricultural products due to market balance [3] Group 3: Potential in Other Crops - There is significant potential for processing development in flax, industrial hemp, and peas, with industrial hemp processing plants and pea bio-adhesive production facilities under construction in industrial parks [3]

Core Viewpoint - The A-share market in 2025 experienced a significant overall rise, with the Shanghai Composite Index up 18.4%, the ChiNext Index soaring nearly 50%, and the Shenzhen Component Index increasing close to 30%. This year marked a rare "true bull market" with over 4,000 stocks rising, accounting for nearly 80% of the total [1]. Group 1: Top Bull Stocks - The top bull stocks of 2025 were driven by trends in AI and mergers and acquisitions, with significant price increases observed across the board [3]. - **Shangwei New Materials**: Achieved a staggering 1827.3% increase due to a control change and a shift from traditional chemicals to humanoid robots, supported by a strong recovery in its main business [4][5]. - **Tiangpu Co., Ltd.**: Experienced a 1645.4% rise, fueled by expectations of a shell merger with an AI chip company, capitalizing on the booming demand for AI models [8][10]. - **ST Yushun**: Saw a 719.4% increase as it successfully transitioned from its old business to AI infrastructure, supported by a significant acquisition [11][12]. - **ST Yanzhen**: Increased by 636.7% due to asset injection and a change in control, transforming its traditional home goods business into a resource stock [13]. - **Shenghong Technology**: Rose by 586.0%, benefiting from its position as a Tier 1 supplier to Nvidia and the growing demand for AI server PCBs [14]. - **Changwo Technology**: Achieved a 581.7% increase, driven by surging orders in the wind power and new energy vehicle sectors [15][16]. - **Feilinger**: Increased by 568.5% due to a change in control and expectations of transitioning to AI home products [17]. - **Dingtaikao Technology**: Saw a 567.1% rise, benefiting from the increased demand for AI server PCB materials [18]. - **Hengbo Co., Ltd.**: Increased by 527.0%, capitalizing on the dual benefits of PEEK material localization and new energy vehicle components [19]. - **Shunhao Co., Ltd.**: Achieved a 507.7% increase, driven by policy support for industrial hemp and new tobacco products [20]. Group 2: Top Bear Stocks - The top bear stocks of 2025 were primarily associated with risks of delisting and deteriorating operations [22]. - **Zitian Technology**: Experienced a dramatic decline of 98.4% due to long-term fraud and refusal to comply with regulatory checks, leading to its forced delisting [23]. - **Delisted Suwu**: Fell by 96.9% after years of inflated profits and financial hollowing, triggering delisting conditions [25]. - **Renle Co., Ltd.**: Dropped by 94.6% due to operational collapse and insolvency, reflecting the impact of e-commerce and mismanagement [27]. - **Guangdao Co., Ltd.**: Declined by 94.2% as the first delisted stock from the Beijing Stock Exchange, due to significant financial fraud [29]. - **Dongtong Co., Ltd.**: Fell by 91.8% due to internal strife and fraud, leading to governance issues [30]. - **Delisted Pengbo**: Experienced a 92.9% drop, marking a record for financial fraud in A-shares, resulting in forced delisting [31]. - **Hengli Co., Ltd.**: Dropped by 92.8% after 21 years of continuous losses, leading to its eventual delisting [32]. - **Gongzhi Co., Ltd.**: Fell by 91.1% due to a collapse in revenue and management issues [34]. - **Zhongcheng Co., Ltd.**: Experienced a 90.5% decline due to blind diversification into new energy and financial fraud [35]. - **ST Changyao**: Dropped by 82.7% due to price cuts from centralized procurement and ongoing fraud investigations [36].

格隆汇12月17日丨溢多利(300381.SZ)在投资者互动平台表示，公司目前没有工业大麻业务。 （原标题：溢多利(300381.SZ)：公司目前没有工业大麻业务） ...

Core Viewpoint - Shunhao Co., Ltd. has experienced a significant stock price increase, with a cumulative rise of over 110% in 11 trading days, leading to a market capitalization of 16.9 billion yuan. However, the company has issued a warning regarding the lack of synergy between its existing business and its investment in Beijing Orbit Chuang Technology Co., Ltd. [2] Company Overview - Shunhao Co., Ltd. operates in four main industries: special anti-counterfeit environmentally friendly paper, printed products, new tobacco, and industrial hemp. The company has subsidiaries located in key regions across China and has extended its operations to the United States, Japan, and Cambodia [3]. - In the first three quarters of 2025, Shunhao Co., Ltd. achieved a net profit attributable to shareholders of 67.319 million yuan, representing a year-on-year growth of 20.29% [3]. Investment in Orbit Chuang - In June 2025, Shunhao Co., Ltd. invested 110 million yuan in Orbit Chuang, acquiring a 19.3% stake. Orbit Chuang's primary business involves launching computing power satellites to establish space data centers, providing computing services to clients [3]. - The business of Orbit Chuang is expected to face challenges, including long commercialization cycles and various regulatory issues, with significant commercial value potentially emerging only in 5 to 10 years [2]. Industry Context - The market is increasingly focusing on space computing as commercial aerospace is integrated into national space development plans. The demand for computing power is expanding across various industries, with space data centers seen as a potential solution to the high energy consumption and heat dissipation issues faced by ground data centers [3]. - However, the space computing sector is still in the early stages of technological validation and industrial cultivation, requiring time for technology to mature and achieve large-scale commercialization [3].

Core Viewpoint - Shunhao Co., Ltd. has experienced a significant stock price increase, with a cumulative rise of over 110% in 11 trading days, leading to a market capitalization of 16.9 billion yuan. However, the company has issued a warning regarding the lack of synergy between its existing business and its investment in Beijing Trajectory Chuang Technology Co., Ltd. [1] Group 1: Company Overview - Shunhao Co., Ltd. operates in four main industries: special anti-counterfeiting environmentally friendly paper, printing products, new tobacco, and industrial hemp. Its subsidiaries are located in key regions across China and have extended operations to the United States, Japan, and Cambodia [2]. - For the first three quarters of 2025, Shunhao Co., Ltd. reported a net profit attributable to shareholders of 67.319 million yuan, representing a year-on-year growth of 20.29% [2]. Group 2: Investment in Trajectory Chuang - In June 2025, Shunhao Co., Ltd. invested 110 million yuan in Trajectory Chuang, acquiring a 19.3% stake. Trajectory Chuang's primary business involves launching computing satellites into the twilight orbit to establish a space data center, providing computing services to clients [2]. - The space computing sector is gaining attention as commercial aerospace is integrated into national space development plans. However, it is noted that space computing is still in the early stages of technological validation and industrial cultivation, requiring time for maturity and large-scale commercialization [2]. Group 3: Risks and Challenges - The announcement from Shunhao Co., Ltd. highlighted that the business of Trajectory Chuang does not create synergies with its existing operations and is subject to various risks, including macroeconomic factors, industry policies, and market environment changes. The commercial value of Trajectory Chuang's "Tianshu Tiansuan" business may only become clear in the next five years, while its "Dishu Tiansuan" business may take 5 to 10 years to compete effectively with ground data centers [1]. - The company emphasized that the investment in Trajectory Chuang would have a minimal impact on its operating performance by 2025, and the development of related industries remains in the early stages, with significant uncertainty regarding future returns [1].

Core Viewpoint - The recent rumors regarding the signing of a 50-ton supply contract with Bayer for 2025 by the company are untrue, and its industrial hemp business is still in the early stages of development, contributing less than 0.1% to the total revenue [1] Group 1 - The company clarified that the rumors about a contract with Bayer are not accurate [1] - The industrial hemp business is currently in its initial development phase [1] - Revenue from the industrial hemp segment accounts for less than 0.1% of the company's total revenue [1]

Core Viewpoint - Shunhao Co., Ltd. plans to issue H shares and list on the Hong Kong Stock Exchange despite declining performance and ongoing legal issues, raising questions about the necessity and feasibility of the IPO [1][10]. Financial Performance - Shunhao's revenue and net profit have been on a downward trend since 2018, with revenue failing to exceed the 2018 peak of 20.55 billion yuan, and net profit showing significant losses in several years [4][5]. - In the first half of 2025, the company reported revenue of 620 million yuan and a net profit of 29 million yuan, representing year-on-year declines of 12.19% and 6.24% respectively [6]. Employee Reduction - The company has reduced its workforce by nearly 50% over the past seven years, from 2,121 employees in 2017 to 1,116 in 2024, indicating ongoing operational challenges [7][9]. Acquisition Issues - Shunhao has faced significant losses due to problematic acquisitions, such as the 2013 purchase of Zhejiang Demei, which led to a loss of 51 million yuan in 2014 due to management misconduct [5][6]. Legal and Compliance Challenges - The company is currently under investigation for alleged unit bribery, which poses a significant obstacle to its IPO plans, as compliance with regulatory standards is critical for approval from both the China Securities Regulatory Commission and the Hong Kong Stock Exchange [11][12][13].

Group 1 - The core viewpoint of the news is that Shunhao Co., Ltd. plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and competitiveness [2] - The company is actively discussing the issuance and listing with relevant intermediaries, and specific details are yet to be finalized [2] - Shunhao Co., Ltd. has appointed Hong Kong Lixin as the auditing firm for this issuance and listing [2] Group 2 - Shunhao Co., Ltd. was established in 2004 and focuses on eco-friendly packaging materials, new tobacco products, and industrial hemp, with a clear business structure [3] - The company employs nearly 1,200 people and has around 30 subsidiaries located in various regions including the US, Cambodia, and several provinces in China [3] - As of August 18, the company's market capitalization is approximately 9.042 billion RMB [3]

Core Viewpoint - The industrial hemp sector experienced a significant surge on December 12, driven by news that former President Trump is considering reclassifying marijuana's danger level, which could lower its regulatory status [1] Market Performance - Fu'an Pharmaceutical rose over 15% - Rhine Biology hit the daily limit up - Morning Light Bio increased nearly 7% - Kang En Bei and Fu Ri Electronics both rose around 6% [1] U.S. Market Reaction - U.S. cannabis stocks saw strong performance on Monday: - Canopy Growth surged over 26% - Tilray Brands jumped over 40% - Cronos Group increased by more than 14%, reaching a 52-week high [1] Industrial Hemp Overview - Industrial hemp is characterized by a tetrahydrocannabinol (THC) content of less than 0.3% and does not exhibit psychoactive effects - Its seeds, flowers, leaves, stalks, and roots can be utilized in textiles, food, daily chemicals, and pharmaceuticals [1] Market Growth Forecast - According to Mordor Intelligence, the global industrial hemp market is projected to grow from $2.21 billion in 2023 to $4.97 billion by 2028 - This represents a compound annual growth rate (CAGR) of 17.56% over the next five years [1]